news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Meijing AI News,Shengxiang Biotech (SH 688289, closing price: 19.53 yuan) announced on August 18 that the company will hold the first extraordinary shareholders' meeting of 2024 at No. 680 Huaxi Road, Minhang District, Shanghai at 14:30 on September 3, 2024. The shareholders' meeting will review proposals such as the "Proposal on the 2024 Semi-annual Profit Distribution Plan of Shengxiang Biotech Co., Ltd.". Shareholders registered after the close of the market on August 28, 2024 can vote on site or exercise their voting rights through the exchange voting system.

From January to December 2023, the operating income structure of Shengxiang Bio was as follows: the in vitro diagnostic industry accounted for 98.41%.

As of press time, the market value of Shengxiang Bio was 11.4 billion yuan.

Daoda No. (daoda1997) "Stock Trend" reminder:

1. In the past 30 days, the northbound funds' holdings of Shengxiang Bio increased by 574,100 shares, and the proportion of outstanding shares increased by 0.11%;

2. No organization has conducted any research on Shengxiang Bio in the past 30 days.

Every headline (nbdtoutiao)——

(Reporter Chen Pengcheng)

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. You will be responsible for your own risks if you act accordingly.

Daily Economic News